FTIR Study on the Effect of DangGuiTongFengFang on Hyperuricemia Nephropathy in Mice
LIU Bi-wang1, LU Rong-rong2, CAO Yue2, WANG Xiu-wen3, ZHAO Huan4, HAO Miao3, MA Xiao-xia3, MA Yan-miao2, WANG Yong-hui2
1. FUSHAN College, Shanxi University of Chinese Medicine, Yuci 030619，China
2. Basic Medicine College, Shanxi University of Chinese Medicine, Yuci 030619，China
3. College of TCM and Food Engineering, Shanxi University of Chinese Medicine, Yuci 030619，China
4. Pharmacy Department, Affiliated Hospital of Shanxi University of Chinese Medicine, Taiyuan 030024，China
Abstract：The Fourier transform infrared spectrometer (FTIR) is an effective method to identify and analyze the structure of substances. It can be used to characterize Quantitative analysis samples and is widely used in many fields, such as medicine and the chemical industry. FTIR, as a simple, practical, accurate and low-cost identification method, has been widely used in drug testing, but its application in pharmacological research is very limited. There are only reports on the study of various kinds of tumor tissues by infrared spectrum analysis. Hyperuricemia nephropathy is a condition in which a high uric acid load exceeds the ability of the kidneys to clear the elevated level of serum uric acid. The uric acid crystals are deposited in collecting ducts, the renal pelvis and the urethra. Therefore, it is feasible to use FTIR to evaluate the Hyperuricemia nephropathy model and evaluate the efficacy of drugs. To explore the feasibility of FTIR in evaluating the Hyperuricemia nephropathy model and the therapeutic effect of DangGuiTongFengFang, 60 km mice were randomly divided into 6 groups, the Rats in the normal control group, model group, positive control group and the low, middle and high groups of the Chinese angelica gouty prescription were treated with potassium oxonateto make the model of Hyperuricemia nephropathy, serum UA, urine UA, serum CRE, urine CRE, serum IL-1β, renal IL-1β and FTIR spectra were detected. The results showed that the indexes of the model group were significantly different from those of the normal group (p<0.05), and the serum levels of UA, CRE, IL-1β and renal IL-1β in the high-dose group were also significantly higher than those in the model group (p<0.05). The pathological changes of the kidney in the high-dose group were improved, with no inflammatory cell infiltration and no tubular type in the lumen, indicating that the high-dose group has a protective effect on the kidney injury. The FTIR spectra of the model group were lower than that of the normal group. The FTIR spectra of the positive control group and the high-dose group of DangGuiTongFengFang were close to that of the normal group. It is further indicated that DangGuiTongFengFang has a protective effect on renal injury. The study shows that FTIR can be used as a simple, quick, flexible and economical method to evaluate the animal model and the therapeutic effect of drugs. It also provides a significant technical means for the Hyperuricemia nephropathy model and the screening of effective drugs. This experiment extends the application range of the FTIR detection method.
刘必旺，路荣荣，曹 越，王秀文，赵 换，郝 渺，马晓霞，马艳苗，王永辉. 当归痛风方对小鼠高尿酸血症肾病的FTIR研究[J]. 光谱学与光谱分析, 2024, 44(03): 800-806.
LIU Bi-wang, LU Rong-rong, CAO Yue, WANG Xiu-wen, ZHAO Huan, HAO Miao, MA Xiao-xia, MA Yan-miao, WANG Yong-hui. FTIR Study on the Effect of DangGuiTongFengFang on Hyperuricemia Nephropathy in Mice. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2024, 44(03): 800-806.
[1] LEI Huan, DENG Qin, LIU Zi-yuan，et al(雷 欢, 邓 琴, 刘子源, 等). Shandong Medical Journal(山东医药), 2022, 62(14): 9.
[2] GUO Ya-fang, DING Ling, QIAO Chun-ping，et al(郭亚芳, 丁 铃, 乔春萍, 等). World Chinese Medicine(世界中医药), 2022, 17(7): 965.
[3] SHUI Guang-xing, YE Jiong, LI Sha-luo, et al(水光兴, 叶 炯, 李莎罗, 等). Chinese Journal of Integrated Traditional and Western Nephrology(中国中西医结合肾病杂志), 2021, 22(10): 878.
[4] WANG Zhong-hui(王忠辉). Laboratory Science（实验室科学）, 2021, 24(5): 15.
[5] WANG De-fa, ZHOU Feng-ran, YE Jing, et al(王德发, 周枫然, 叶 菁, 等). Metrology Science and Technology(计量科学与技术), 2021, 65(5): 67.
[6] DONG Qin, KONG Guang-zhong，QIN Fei, et al（董 勤, 孔广忠, 秦 斐, 等）. Acta Acad. Med. Nei Mongol.（内蒙古医学院学报), 2002, 24(4): 236.
[7] SUN Lei-ming, TANG Wei-yue, GUO Ke-min, et al(孙雷明, 唐伟跃, 郭克民, 等). Laser & Infrared(激光与红外), 2005, 35(8): 587.
[8] TANG Wei-yue, LIU Wan-hua, SUN Lei-ming, et al(唐伟跃, 刘婉华, 孙雷明, 等). Laser Journal(激光杂志), 2007, 28(3): 91.
[9] WANG Lei, WANG Qi, LIN Han-cheng, et al(王 磊, 王 琪, 林汉成, 等). Journal of Forensic Medicine（法医学杂志), 2018, 34(3): 223.
[10] LI Gun, PANG Xiao-feng(李 滚, 庞小峰). Laser Journal(激光杂志), 2013, 34(3): 43.
[11] XUAN Miao-gen, FU Gao-wen, LIU Feng, et al(宣妙根, 付高文, 刘 峰, 等). Journal of Forensic Medicine（法医学杂志）, 2013, 29(1): 1.
[12] YUAN Yi-zhong, CUI Jian-min, SHEN Wen(袁仪忠, 崔建民, 沈 文). International Journal of Medical Radiology(国际医学放射学杂志), 2021, 44(2): 197.
[13] HE Ya-feng, LI Hai-bin, SONG Bo-feng(贺亚峰, 李海滨, 宋博峰). Guizhou Medical Journal(贵州医药), 2021, 45(12): 1905.
[14] Mortada I. Curr. Hypertens Rep., 2017, 19(9): 69.
